We combined patient data from The Cancer Genome Atlas (TCGA) with our own oesophageal adenocarcinoma data (OCCAMS) as part of the International Cancer Genome Consortium, in which KCNQ3 is recurrently missense mutated in 9.4% of patients (10). This evidence concerns the gene KCNQ3 and cancer.